Press releases | WebDisclosure

Basculer en Français

10373	Companies
216184	Keywords
145886	Articles
114463	Press releases

Home
Press releases

REGULATED PRESS RELEASE

published on 05/22/2025 at 17:50, 11 months 18 days ago

Press release relating to the availability of the preparatory documents - GM to be held on June 12, 2025
ALTEN SA announces the Combined Ordinary and Extraordinary General Meeting on 12 June 2025. Preparatory documents available online for shareholders

Shareholders French Commercial Code ALTEN SA General Meeting Preparatory Documents
REGULATED PRESS RELEASE

published on 05/22/2025 at 17:50, 11 months 18 days ago

Communiqué de mise à disposition des documents préparatoires - Assemblée Générale du 12 juin 2025
ALTEN tiendra son Assemblée Générale Mixte le 12 juin 2025 à Boulogne-Billancourt. Les documents préparatoires sont disponibles en ligne pour les actionnaires

Euronext Paris Actionnaires ALTEN Documents Préparatoires Assemblée Générale Mixte
PRESS RELEASE

published on 05/22/2025 at 17:45, 11 months 18 days ago

COOFANDY Marks 10th Anniversary with Dual Silver Awards at Berlin and New York Product Design Competitions
COOFANDY Men's Short-Sleeve Casual Shirts receive Silver Awards at 2025 Berlin Design Awards and New York Product Design Awards, showcasing brand's design prowess and commitment to quality and sustainability

Innovation Sustainability Design Awards COOFANDY Men's Shirts
REGULATED PRESS RELEASE

published on 05/22/2025 at 17:45, 11 months 18 days ago

NFL Biosciences lance une levée de fonds d’environ 2,2 millions d’euros par voie d’augmentations de capital
NFL Biosciences lance une levée de fonds de 2,2 millions d'euros pour étude sur le traitement des addictions avec nouveau médicament NFL-101

NFL Biosciences NFL-101 Levée De Fonds Addictions Étude Phase 3
REGULATED PRESS RELEASE

published on 05/22/2025 at 17:45, 11 months 18 days ago

NFL Biosciences launches a capital increase of approximately €2.2 million
NFL Biosciences launches a €2.2 million capital increase through global offering for smoking cessation drug development. Subscription price: €1.20/share

NFL Biosciences Capital Increase Smoking Cessation Subscription Price Global Offering
PRESS RELEASE

published on 05/22/2025 at 17:45, 11 months 18 days ago

Transgene to Present 24-month Disease-Free Survival Data from All Patients in Phase I Part of Trial of Individualized Cancer Vaccine, TG4050, at ASCO 2025
Transgene to present 24-month disease-free survival data from all patients in Phase I part of trial of individualized cancer vaccine, TG4050, at ASCO 2025

Cancer Vaccine Transgene TG4050 ASCO 2025 Disease-free Survival
PRESS RELEASE

published on 05/22/2025 at 17:45, 11 months 18 days ago

TOUAX : Modalités de mise à disposition des documents préparatoires Assemblée générale mixte de TOUAX SCA du 12 juin 2025
TOUAX convoque ses actionnaires en assemblée générale mixte le 12 juin 2025. Documents disponibles en ligne ou sur demande. Leader de la location d'actifs tangibles

Assemblée Générale Documents Préparatoires Touax CAC Small Location D'actifs
PRESS RELEASE

published on 05/22/2025 at 17:45, 11 months 18 days ago

Touax: availibility of documents shareholder's meeting 12 06 2025
TOUAX announces Annual Shareholders' Meeting on June 12, 2025 at Châteauform' Learning Lab La Défense, 92800 Puteaux, France. Information available on company's website

Shareholders' Meeting Sustainable Transportation Touax Operational Leasing
PRESS RELEASE

published on 05/22/2025 at 17:40, 11 months 18 days ago

VALBIOTIS SA: Valbiotis to launch ValbiotisPRO® Cardio-circulation on 2 June
Valbiotis announces the launch of ValbiotisPRO® Cardio-circulation on 2 June, expanding its range of scientifically tested dietary supplements to support cardiometabolic balance. Multichannel marketing strategy accelerates with listings in supplemental insurance companies

Dietary Supplements Scientific Multichannel Marketing ValbiotisPRO® Cardio-circulation Cardiometabolic Balance
PRESS RELEASE

published on 05/22/2025 at 17:40, 11 months 18 days ago

VALBIOTIS SA: Valbiotis commercialisera le 2 juin prochain sa solution ValbiotisPRO® Cardio-circulation
Valbiotis commercialisera le 2 juin prochain sa solution ValbiotisPRO® Cardio-circulation, renforçant sa stratégie de commercialisation multicanal et de référencement

Commercialisation Valbiotis Référencement ValbiotisPRO® Cardio-circulation Gamme

Accesswire

Published on 05/09/2026 at 01:55, 1 day 12 hours ago

Prospect Ridge Announces Board Resignation
Published on 05/09/2026 at 01:40, 1 day 12 hours ago

Findev Inc. Issues Corrective Disclosure
Published on 05/09/2026 at 01:30, 1 day 12 hours ago

Star Copper Announces Agreement with Zimtu Capital Corp.
Published on 05/09/2026 at 00:00, 1 day 14 hours ago

Onco-Innovations Progresses Toward IND Preparation as Nucro-Technics Commences Bioanalysis for PNKP Inhibitor Technology
Published on 05/08/2026 at 23:01, 1 day 15 hours ago

Water Ways Announces Corporate Updates

View all ACCESSWIRE

EQS Group

Published on 05/10/2026 at 14:00, 16 minutes ago

MBC GROUP DELIVERS RESILIENT 1Q 2026 PERFORMANCE ANCHORED BY STRONG MBC SHAHID GROWTH
Published on 05/10/2026 at 11:45, 2 hours 31 minutes ago

Hisense Kicks Off FIFA World Cup 2026™ Campaign, Bringing Fans Closer Through "Innovating a Brighter Life"
Published on 05/09/2026 at 19:05, 19 hours 11 minutes ago

LONGi EcoLife Series Module Top TaiyangNews Global Ranking, Ushering in the "25%+" Era of Photovoltaic Efficiency
Published on 05/08/2026 at 20:38, 1 day 17 hours ago

EQS-Adhoc: thyssenkrupp nucera AG & Co. KGaA: Preliminary Figures for Q2/6M 2025/26; Order Intake Above Expectations and Previous Year ; Sales and Earnings below Market Expectations
Published on 05/08/2026 at 19:12, 1 day 19 hours ago

EQS-Adhoc: Viromed Medical AG missed revenue forecast for 2025 financial year, but continued to grow significantly and achieved a positive result; revised forecast for 2026

Les Echos

Published on 05/07/2026 at 19:15, 2 days 19 hours ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 2 days 19 hours ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 2 days 19 hours ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 2 days 19 hours ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 2 days 19 hours ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE